Search Genes

GET /api/v1/genes/?format=api&page=88
HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 35535,
    "next": "https://panelapp-aus.org/api/v1/genes/?format=api&page=89",
    "previous": "https://panelapp-aus.org/api/v1/genes/?format=api&page=87",
    "results": [
        {
            "gene_data": {
                "alias": [
                    "OG2",
                    "Og2x"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:22448",
                "gene_name": "NOBOX oogenesis homeobox",
                "omim_gene": [
                    "610934"
                ],
                "alias_name": [
                    "newborn ovary homeobox-encoding gene"
                ],
                "gene_symbol": "NOBOX",
                "hgnc_symbol": "NOBOX",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:144094333-144107320",
                            "ensembl_id": "ENSG00000106410"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:144397240-144410227",
                            "ensembl_id": "ENSG00000106410"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-05-19"
            },
            "entity_type": "gene",
            "entity_name": "NOBOX",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "27836978",
                "21837770",
                "25514101",
                "17701902",
                "27798098",
                "29067606"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Premature ovarian failure 5,MIM#611548"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ZIBRA",
                    "FLJ10111",
                    "FLJ23501",
                    "HOIP",
                    "Paul"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:16031",
                "gene_name": "ring finger protein 31",
                "omim_gene": [
                    "612487"
                ],
                "alias_name": [
                    "HOIL-1-interacting protein"
                ],
                "gene_symbol": "RNF31",
                "hgnc_symbol": "RNF31",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:24615892-24629870",
                            "ensembl_id": "ENSG00000092098"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:24146683-24160661",
                            "ensembl_id": "ENSG00000092098"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-09-29"
            },
            "entity_type": "gene",
            "entity_name": "RNF31",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "26008899",
                "30936877",
                "39009172",
                "41026334"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Immunodeficiency 115 with autoinflammation, MIM# 620632"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "TRIAD3",
                    "UBCE7IP1",
                    "ZIN"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21698",
                "gene_name": "ring finger protein 216",
                "omim_gene": [
                    "609948"
                ],
                "alias_name": null,
                "gene_symbol": "RNF216",
                "hgnc_symbol": "RNF216",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:5659678-5821370",
                            "ensembl_id": "ENSG00000011275"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:5620047-5781739",
                            "ensembl_id": "ENSG00000011275"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-08-20"
            },
            "entity_type": "gene",
            "entity_name": "RNF216",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "23656588"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert list",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Cerebellar ataxia and hypogonadotropic hypogonadism MIM#212840"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA1554",
                    "NET57"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14539",
                "gene_name": "ring finger protein 213",
                "omim_gene": [
                    "613768"
                ],
                "alias_name": null,
                "gene_symbol": "RNF213",
                "hgnc_symbol": "RNF213",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:78234665-78372586",
                            "ensembl_id": "ENSG00000173821"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:80260866-80398786",
                            "ensembl_id": "ENSG00000173821"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-02-08"
            },
            "entity_type": "gene",
            "entity_name": "RNF213",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "37924258",
                "28635953"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Susceptibility to Moyamoya disease 2, (MIM# 607151)"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ38841"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:27729",
                "gene_name": "ring finger protein 212",
                "omim_gene": [
                    "612041"
                ],
                "alias_name": null,
                "gene_symbol": "RNF212",
                "hgnc_symbol": "RNF212",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:1050038-1107350",
                            "ensembl_id": "ENSG00000178222"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:1056250-1113562",
                            "ensembl_id": "ENSG00000178222"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-01-19"
            },
            "entity_type": "gene",
            "entity_name": "RNF212",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "18239089",
                "29277047",
                "31125047",
                "23396135"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Recombination rate QTL 1, MIM#612042",
                "Spermatogenic failure 62, MIM# 619673"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "DKFZP564A022",
                    "ADSA"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:25358",
                "gene_name": "ring finger protein 170",
                "omim_gene": [
                    "614649"
                ],
                "alias_name": null,
                "gene_symbol": "RNF170",
                "hgnc_symbol": "RNF170",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "8:42704780-42752433",
                            "ensembl_id": "ENSG00000120925"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "8:42849637-42897290",
                            "ensembl_id": "ENSG00000120925"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-01-26"
            },
            "entity_type": "gene",
            "entity_name": "RNF170",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Spastic paraplegia 85, autosomal recessive, MIM# 619686",
                "Ataxia, sensory, 1, autosomal dominant, MIM# 608984"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "BLAU",
                    "CD",
                    "PSORAS1",
                    "CLR16.3",
                    "NLRC2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:5331",
                "gene_name": "nucleotide binding oligomerization domain containing 2",
                "omim_gene": [
                    "605956"
                ],
                "alias_name": [
                    "nucleotide-binding oligomerization domain, leucine rich repeat and CARD domain containing 2",
                    "NOD-like receptor C2",
                    "NLR family, CARD domain containing 2"
                ],
                "gene_symbol": "NOD2",
                "hgnc_symbol": "NOD2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:50727514-50766988",
                            "ensembl_id": "ENSG00000167207"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:50693603-50734041",
                            "ensembl_id": "ENSG00000167207"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-12-08"
            },
            "entity_type": "gene",
            "entity_name": "NOD2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "15459013",
                "11385576",
                "17804789",
                "32463623",
                "33692434",
                "39372397"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Blau syndrome, MIM# 186580",
                "{Inflammatory bowel disease 1, Crohn disease} 266600",
                "{Yao syndrome} 617321"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7865",
                "gene_name": "nodal growth differentiation factor",
                "omim_gene": [
                    "601265"
                ],
                "alias_name": null,
                "gene_symbol": "NODAL",
                "hgnc_symbol": "NODAL",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "10:72192071-72207707",
                            "ensembl_id": "ENSG00000156574"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "10:70432315-70447951",
                            "ensembl_id": "ENSG00000156574"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-06-05"
            },
            "entity_type": "gene",
            "entity_name": "NODAL",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "9354794",
                "19064609",
                "29368431",
                "19933292",
                "11311163",
                "30293987"
            ],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Heterotaxy, visceral, 5 (MIM#270100)"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [
                "disputed"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7866",
                "gene_name": "noggin",
                "omim_gene": [
                    "602991"
                ],
                "alias_name": null,
                "gene_symbol": "NOG",
                "hgnc_symbol": "NOG",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:54671060-54672951",
                            "ensembl_id": "ENSG00000183691"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:56593699-56595590",
                            "ensembl_id": "ENSG00000183691"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-03-24"
            },
            "entity_type": "gene",
            "entity_name": "NOG",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "11846737",
                "18440889",
                "12089654",
                "10080184",
                "15066478",
                "22088931",
                "17381491"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "NOG-related symphalangism spectrum disorder MONDO:0100521"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ARC",
                    "NOP30",
                    "MYP",
                    "CARD2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7869",
                "gene_name": "nucleolar protein 3",
                "omim_gene": [
                    "605235"
                ],
                "alias_name": null,
                "gene_symbol": "NOL3",
                "hgnc_symbol": "NOL3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:67204057-67209643",
                            "ensembl_id": "ENSG00000140939"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:67170154-67175735",
                            "ensembl_id": "ENSG00000140939"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-01-13"
            },
            "entity_type": "gene",
            "entity_name": "NOL3",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "22926851"
            ],
            "evidence": [
                "Expert Review Red",
                "Royal Melbourne Hospital",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Myoclonus, familial, 1 MIM#614937"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NRB54",
                    "NMT55",
                    "P54NRB",
                    "P54",
                    "PPP1R114"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7871",
                "gene_name": "non-POU domain containing octamer binding",
                "omim_gene": [
                    "300084"
                ],
                "alias_name": [
                    "Nuclear RNA-binding protein, 54-kD",
                    "non-Pou domain-containing octamer (ATGCAAAT) binding protein",
                    "protein phosphatase 1, regulatory subunit 114"
                ],
                "gene_symbol": "NONO",
                "hgnc_symbol": "NONO",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:70503042-70521018",
                            "ensembl_id": "ENSG00000147140"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:71283192-71301168",
                            "ensembl_id": "ENSG00000147140"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1992-02-06"
            },
            "entity_type": "gene",
            "entity_name": "NONO",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "26571461",
                "27329731",
                "27550220"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Intellectual developmental disorder, X-linked syndromic 34 - MIM#300967"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NOP10P",
                    "MGC70651"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14378",
                "gene_name": "NOP10 ribonucleoprotein",
                "omim_gene": [
                    "606471"
                ],
                "alias_name": [
                    "homolog of yeast Nop10p"
                ],
                "gene_symbol": "NOP10",
                "hgnc_symbol": "NOP10",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "15:34633917-34635378",
                            "ensembl_id": "ENSG00000182117"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "15:34341713-34343177",
                            "ensembl_id": "ENSG00000182117"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2008-10-13"
            },
            "entity_type": "gene",
            "entity_name": "NOP10",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "17507419",
                "32554502",
                "32139460"
            ],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Dyskeratosis congenita, autosomal recessive 1, MIM#224230",
                "Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 9, MIM# 620400"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "SCA36"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:15911",
                "gene_name": "NOP56 ribonucleoprotein",
                "omim_gene": [
                    "614154"
                ],
                "alias_name": [
                    "spinocerebellar ataxia 36"
                ],
                "gene_symbol": "NOP56",
                "hgnc_symbol": "NOP56",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "20:2632791-2639039",
                            "ensembl_id": "ENSG00000101361"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "20:2652145-2658393",
                            "ensembl_id": "ENSG00000101361"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2009-01-13"
            },
            "entity_type": "gene",
            "entity_name": "NOP56",
            "confidence_level": "0",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Removed",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [],
            "mode_of_inheritance": "Unknown",
            "tags": [
                "STR"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0464",
                    "CAPON"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:16859",
                "gene_name": "nitric oxide synthase 1 adaptor protein",
                "omim_gene": [
                    "605551"
                ],
                "alias_name": [
                    "C-terminal PDZ domain ligand of neuronal nitric oxide synthase"
                ],
                "gene_symbol": "NOS1AP",
                "hgnc_symbol": "NOS1AP",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:162039564-162353321",
                            "ensembl_id": "ENSG00000198929"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:162069774-162370475",
                            "ensembl_id": "ENSG00000198929"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-06-15"
            },
            "entity_type": "gene",
            "entity_name": "NOS1AP",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Nephrotic syndrome, type 22, MIM# 619155"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "iNOS",
                    "NOS",
                    "HEP-NOS"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7873",
                "gene_name": "nitric oxide synthase 2",
                "omim_gene": [
                    "163730"
                ],
                "alias_name": null,
                "gene_symbol": "NOS2",
                "hgnc_symbol": "NOS2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:26083792-26127525",
                            "ensembl_id": "ENSG00000007171"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:27756766-27800499",
                            "ensembl_id": "ENSG00000007171"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2008-09-16"
            },
            "entity_type": "gene",
            "entity_name": "NOS2",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "12433515",
                "31995689"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "{Malaria, resistance to} 611162",
                "Disseminated CMV disease"
            ],
            "mode_of_inheritance": "Unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ECNOS",
                    "eNOS"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7876",
                "gene_name": "nitric oxide synthase 3",
                "omim_gene": [
                    "163729"
                ],
                "alias_name": [
                    "endothelial nitric oxide synthase"
                ],
                "gene_symbol": "NOS3",
                "hgnc_symbol": "NOS3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:150688083-150711676",
                            "ensembl_id": "ENSG00000164867"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:150990995-151014588",
                            "ensembl_id": "ENSG00000164867"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1993-08-23"
            },
            "entity_type": "gene",
            "entity_name": "NOS3",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "24986538",
                "28084234",
                "33652340",
                "36941667",
                "37383439"
            ],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Moyamoya disease 8, MIM#\t621469"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7881",
                "gene_name": "notch 1",
                "omim_gene": [
                    "190198"
                ],
                "alias_name": null,
                "gene_symbol": "NOTCH1",
                "hgnc_symbol": "NOTCH1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:139388896-139440314",
                            "ensembl_id": "ENSG00000148400"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:136494444-136545862",
                            "ensembl_id": "ENSG00000148400"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1992-02-13"
            },
            "entity_type": "gene",
            "entity_name": "NOTCH1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "Other",
            "publications": [
                "25963545",
                "25132448",
                "35947102"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Adams-Oliver syndrome 5 (MIM#616028)",
                "Genetic cerebral small vessel disease (MONDO:0018787), NOTCH1-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7882",
                "gene_name": "notch 2",
                "omim_gene": [
                    "600275"
                ],
                "alias_name": null,
                "gene_symbol": "NOTCH2",
                "hgnc_symbol": "NOTCH2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:120454176-120612240",
                            "ensembl_id": "ENSG00000134250"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:119911553-120069626",
                            "ensembl_id": "ENSG00000134250"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1994-11-10"
            },
            "entity_type": "gene",
            "entity_name": "NOTCH2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "16773578",
                "21378985",
                "21378989"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Alagille syndrome 2 (MIM#610205)",
                "Hajdu-Cheney syndrome (MIM#102500)"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MOP4",
                    "PASD4",
                    "bHLHe9"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7895",
                "gene_name": "neuronal PAS domain protein 2",
                "omim_gene": [
                    "603347"
                ],
                "alias_name": null,
                "gene_symbol": "NPAS2",
                "hgnc_symbol": "NPAS2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:101436614-101613291",
                            "ensembl_id": "ENSG00000170485"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:100820152-100996829",
                            "ensembl_id": "ENSG00000170485"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-05-29"
            },
            "entity_type": "gene",
            "entity_name": "NPAS2",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "25956372"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Non-obstructive azoospermia"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "JBTS4",
                    "SLSN1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7905",
                "gene_name": "nephrocystin 1",
                "omim_gene": [
                    "607100"
                ],
                "alias_name": null,
                "gene_symbol": "NPHP1",
                "hgnc_symbol": "NPHP1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:110879888-110962643",
                            "ensembl_id": "ENSG00000144061"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:110122311-110205066",
                            "ensembl_id": "ENSG00000144061"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1991-08-08"
            },
            "entity_type": "gene",
            "entity_name": "NPHP1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "15138899",
                "32139166",
                "28347285",
                "8852662",
                "9856524"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Joubert syndrome 4, MIM# 609583",
                "Nephronophthisis 1, juvenile, MIM# 256100",
                "Senior-Loken syndrome-1, MIM# 266900"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "SV/CNV"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NPH3",
                    "KIAA2000",
                    "FLJ30691",
                    "FLJ36696",
                    "MKS7",
                    "SLSN3",
                    "CFAP31"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7907",
                "gene_name": "nephrocystin 3",
                "omim_gene": [
                    "608002"
                ],
                "alias_name": [
                    "Meckel syndrome, type 7",
                    "cilia and flagella associated protein 31"
                ],
                "gene_symbol": "NPHP3",
                "hgnc_symbol": "NPHP3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:132276986-132441303",
                            "ensembl_id": "ENSG00000113971"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:132680609-132722442",
                            "ensembl_id": "ENSG00000113971"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-01-20"
            },
            "entity_type": "gene",
            "entity_name": "NPHP3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Meckel syndrome 7, MIM# 267010",
                "Nephronophthisis 3, MIM# 604387",
                "Renal-hepatic-pancreatic dysplasia 1, MIM# 208540"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "SLSN4",
                    "KIAA0673",
                    "POC10"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:19104",
                "gene_name": "nephrocystin 4",
                "omim_gene": [
                    "607215"
                ],
                "alias_name": [
                    "nephroretinin",
                    "POC10 centriolar protein homolog (Chlamydomonas)"
                ],
                "gene_symbol": "NPHP4",
                "hgnc_symbol": "NPHP4",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:5922871-6052533",
                            "ensembl_id": "ENSG00000131697"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:5862811-5992473",
                            "ensembl_id": "ENSG00000131697"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-10-03"
            },
            "entity_type": "gene",
            "entity_name": "NPHP4",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "12244321",
                "12205563",
                "34013113"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Nephronophthisis 4, MIM# 606966",
                "Senior-Loken syndrome 4, MIM# 606996"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CNF",
                    "NPHN"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7908",
                "gene_name": "NPHS1, nephrin",
                "omim_gene": [
                    "602716"
                ],
                "alias_name": null,
                "gene_symbol": "NPHS1",
                "hgnc_symbol": "NPHS1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:36316866-36360189",
                            "ensembl_id": "ENSG00000161270"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:35825964-35869287",
                            "ensembl_id": "ENSG00000161270"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1994-12-14"
            },
            "entity_type": "gene",
            "entity_name": "NPHS1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Nephrotic syndrome, type 1, MIM# 256300"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "SRN1",
                    "PDCN"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:13394",
                "gene_name": "NPHS2, podocin",
                "omim_gene": [
                    "604766"
                ],
                "alias_name": null,
                "gene_symbol": "NPHS2",
                "hgnc_symbol": "NPHS2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:179519674-179545087",
                            "ensembl_id": "ENSG00000116218"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:179550539-179575952",
                            "ensembl_id": "ENSG00000116218"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-11-21"
            },
            "entity_type": "gene",
            "entity_name": "NPHS2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "32467597",
                "30260545",
                "24509478"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Nephrotic syndrome, type 2 (MIM#600995), AR"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7939",
                "gene_name": "natriuretic peptide A",
                "omim_gene": [
                    "108780"
                ],
                "alias_name": null,
                "gene_symbol": "NPPA",
                "hgnc_symbol": "NPPA",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:11905766-11908402",
                            "ensembl_id": "ENSG00000175206"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:11845709-11848345",
                            "ensembl_id": "ENSG00000175206"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1986-01-01"
            },
            "entity_type": "gene",
            "entity_name": "NPPA",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "18614783",
                "20064500",
                "31034774",
                "31077706",
                "40838933",
                "23275345"
            ],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Atrial fibrillation, familial, 6, (MIM#612201)"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CNP"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7941",
                "gene_name": "natriuretic peptide C",
                "omim_gene": [
                    "600296"
                ],
                "alias_name": null,
                "gene_symbol": "NPPC",
                "hgnc_symbol": "NPPC",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:232786530-232791113",
                            "ensembl_id": "ENSG00000163273"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:231921820-231926403",
                            "ensembl_id": "ENSG00000163273"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1993-11-30"
            },
            "entity_type": "gene",
            "entity_name": "NPPC",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "28661490",
                "32528716"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "short stature and non-specific skeletal anomalies - MONDO#0014551"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "GUCY2B",
                    "ANPb"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7944",
                "gene_name": "natriuretic peptide receptor 2",
                "omim_gene": [
                    "108961"
                ],
                "alias_name": [
                    "guanylate cyclase 2B"
                ],
                "gene_symbol": "NPR2",
                "hgnc_symbol": "NPR2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:35792151-35809729",
                            "ensembl_id": "ENSG00000159899"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:35792154-35809732",
                            "ensembl_id": "ENSG00000159899"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1990-03-27"
            },
            "entity_type": "gene",
            "entity_name": "NPR2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "31555216",
                "16384845",
                "15146390",
                "22870295",
                "24057292",
                "24259409",
                "16384845",
                "24471569"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Acromesomelic dysplasia, Maroteaux type MIM# 602875",
                "Epiphyseal chondrodysplasia, Miura type, MIM# 615923",
                "Short stature with nonspecific skeletal abnormalities, MIM# 616255"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "GUCY2B",
                    "FLJ14054"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7945",
                "gene_name": "natriuretic peptide receptor 3",
                "omim_gene": [
                    "108962"
                ],
                "alias_name": [
                    "guanylate cyclase C"
                ],
                "gene_symbol": "NPR3",
                "hgnc_symbol": "NPR3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "5:32689176-32791819",
                            "ensembl_id": "ENSG00000113389"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "5:32689070-32791724",
                            "ensembl_id": "ENSG00000113389"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1990-03-27"
            },
            "entity_type": "gene",
            "entity_name": "NPR3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "30032985"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Boudin-Mortier syndrome, MIM#619543",
                "Tall stature, skeletal abnormalities, aortic dilatation"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NPR2L",
                    "NPR2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:24969",
                "gene_name": "NPR2 like, GATOR1 complex subunit",
                "omim_gene": [
                    "607072"
                ],
                "alias_name": null,
                "gene_symbol": "NPRL2",
                "hgnc_symbol": "NPRL2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:50384761-50388522",
                            "ensembl_id": "ENSG00000114388"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:50347330-50351091",
                            "ensembl_id": "ENSG00000114388"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2010-03-30"
            },
            "entity_type": "gene",
            "entity_name": "NPRL2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "26505888",
                "27173016",
                "28199897",
                "31594065"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Epilepsy, familial focal, with variable foci 2, MIM#\t617116",
                "focal seizures",
                "frontal lobe epilepsy",
                "nocturnal frontal lobe epilepsy",
                "temporal lobe epilepsy",
                "focal cortical dysplasia"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CGTHBA",
                    "RMD11",
                    "NPR3",
                    "MARE",
                    "HS-40"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14124",
                "gene_name": "NPR3 like, GATOR1 complex subunit",
                "omim_gene": [
                    "600928"
                ],
                "alias_name": [
                    "conserved gene telomeric to alpha globin cluster"
                ],
                "gene_symbol": "NPRL3",
                "hgnc_symbol": "NPRL3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:134273-188859",
                            "ensembl_id": "ENSG00000103148"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:84271-138860",
                            "ensembl_id": "ENSG00000103148"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2010-03-30"
            },
            "entity_type": "gene",
            "entity_name": "NPRL3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "27173016",
                "26285051",
                "33461085"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Epilepsy, familial focal, with variable foci 3- MIM#617118"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "PGR14",
                    "GPRA"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:23631",
                "gene_name": "neuropeptide S receptor 1",
                "omim_gene": [
                    "608595"
                ],
                "alias_name": null,
                "gene_symbol": "NPSR1",
                "hgnc_symbol": "NPSR1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:34697851-34917944",
                            "ensembl_id": "ENSG00000187258"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:34658239-34878332",
                            "ensembl_id": "ENSG00000187258"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-05-10"
            },
            "entity_type": "gene",
            "entity_name": "NPSR1",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "31619542"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Short sleep, familial natural, 3, MIM# 621336",
                "{Asthma, susceptibility to, 2}\t608584"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "DAX1",
                    "AHCH"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7960",
                "gene_name": "nuclear receptor subfamily 0 group B member 1",
                "omim_gene": [
                    "300473"
                ],
                "alias_name": null,
                "gene_symbol": "NR0B1",
                "hgnc_symbol": "NR0B1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:30322323-30327715",
                            "ensembl_id": "ENSG00000169297"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:30304206-30309598",
                            "ensembl_id": "ENSG00000169297"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1986-01-01"
            },
            "entity_type": "gene",
            "entity_name": "NR0B1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "19508677",
                "26030781"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Adrenal hypoplasia, congenital (MIM# 300200)",
                "46XY sex reversal 2, dosage-sensitive, MIM#\t300018"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [
                "SV/CNV"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "SHP"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7961",
                "gene_name": "nuclear receptor subfamily 0 group B member 2",
                "omim_gene": [
                    "604630"
                ],
                "alias_name": null,
                "gene_symbol": "NR0B2",
                "hgnc_symbol": "NR0B2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:27237980-27240457",
                            "ensembl_id": "ENSG00000131910"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:26911489-26913966",
                            "ensembl_id": "ENSG00000131910"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-08-19"
            },
            "entity_type": "gene",
            "entity_name": "NR0B2",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Obesity, mild, early-onset, MIM#\t601665"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FXR",
                    "RIP14",
                    "HRR1",
                    "HRR-1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7967",
                "gene_name": "nuclear receptor subfamily 1 group H member 4",
                "omim_gene": [
                    "603826"
                ],
                "alias_name": [
                    "farnesoid X receptor"
                ],
                "gene_symbol": "NR1H4",
                "hgnc_symbol": "NR1H4",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:100867486-100958191",
                            "ensembl_id": "ENSG00000012504"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:100473708-100564413",
                            "ensembl_id": "ENSG00000012504"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-09-17"
            },
            "entity_type": "gene",
            "entity_name": "NR1H4",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "26888176",
                "32443034"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Cholestasis, progressive familial intrahepatic, 5, MIM# 617049"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "TLL",
                    "XTLL"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7973",
                "gene_name": "nuclear receptor subfamily 2 group E member 1",
                "omim_gene": [
                    "603849"
                ],
                "alias_name": null,
                "gene_symbol": "NR2E1",
                "hgnc_symbol": "NR2E1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:108487262-108510013",
                            "ensembl_id": "ENSG00000112333"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:108166058-108188809",
                            "ensembl_id": "ENSG00000112333"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-07-15"
            },
            "entity_type": "gene",
            "entity_name": "NR2E1",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [],
            "mode_of_inheritance": "Unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "PNR",
                    "rd7",
                    "RP37"
                ],
                "biotype": null,
                "hgnc_id": "HGNC:7974",
                "gene_name": "nuclear receptor subfamily 2 group E member 3",
                "omim_gene": [
                    "604485"
                ],
                "alias_name": null,
                "gene_symbol": "NR2E3",
                "hgnc_symbol": "NR2E3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "15:72084977-72110600",
                            "ensembl_id": "ENSG00000031544"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "15:71792638-71818259",
                            "ensembl_id": "ENSG00000278570"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-09-16"
            },
            "entity_type": "gene",
            "entity_name": "NR2E3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20301590",
                "30324420",
                "19718767",
                "33138239"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Retinitis pigmentosa 37 - MIM#611131",
                "Enhanced S-cone syndrome - MIM#268100",
                "Goldmann-Favre syndrome - MONDO#0100289",
                "retinal dystrophy"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "EAR-3",
                    "COUP-TFI",
                    "TCFCOUP1",
                    "SVP44"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7975",
                "gene_name": "nuclear receptor subfamily 2 group F member 1",
                "omim_gene": [
                    "132890"
                ],
                "alias_name": null,
                "gene_symbol": "NR2F1",
                "hgnc_symbol": "NR2F1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "5:92919043-92930321",
                            "ensembl_id": "ENSG00000175745"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "5:93583337-93594615",
                            "ensembl_id": "ENSG00000175745"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1995-03-21"
            },
            "entity_type": "gene",
            "entity_name": "NR2F1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "32275123"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Bosch-Boonstra-Schaaf optic atrophy syndrome, MIM# 615722"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "COUP-TFII",
                    "COUPTFB",
                    "SVP40",
                    "NF-E3"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7976",
                "gene_name": "nuclear receptor subfamily 2 group F member 2",
                "omim_gene": [
                    "107773"
                ],
                "alias_name": null,
                "gene_symbol": "NR2F2",
                "hgnc_symbol": "NR2F2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "15:96869167-96883492",
                            "ensembl_id": "ENSG00000185551"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "15:96325938-96340263",
                            "ensembl_id": "ENSG00000185551"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1995-03-21"
            },
            "entity_type": "gene",
            "entity_name": "NR2F2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "37500725",
                "24702954",
                "29478779",
                "31687637",
                "27363585",
                "29222010",
                "29663647"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Syndromic disease, MONDO:0002254, NR2F2-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "GR"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7978",
                "gene_name": "nuclear receptor subfamily 3 group C member 1",
                "omim_gene": [
                    "138040"
                ],
                "alias_name": [
                    "glucocorticoid receptor"
                ],
                "gene_symbol": "NR3C1",
                "hgnc_symbol": "NR3C1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "5:142657496-142815077",
                            "ensembl_id": "ENSG00000113580"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "5:143277931-143435512",
                            "ensembl_id": "ENSG00000113580"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "NR3C1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "12754700",
                "1704018",
                "8445027",
                "31995340",
                "30158362"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Glucocorticoid resistance, OMIM # 615962"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MR"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7979",
                "gene_name": "nuclear receptor subfamily 3 group C member 2",
                "omim_gene": [
                    "600983"
                ],
                "alias_name": null,
                "gene_symbol": "NR3C2",
                "hgnc_symbol": "NR3C2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:148999913-149365850",
                            "ensembl_id": "ENSG00000151623"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:148078762-148444698",
                            "ensembl_id": "ENSG00000151623"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1988-08-19"
            },
            "entity_type": "gene",
            "entity_name": "NR3C2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "9662404",
                "11134129",
                "11344206",
                "12788847",
                "16972228"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Pseudohypoaldosteronism type I, autosomal dominant, MIM# 177735",
                "MONDO:0008329"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CSMF",
                    "CHN",
                    "NOR1",
                    "MINOR"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7982",
                "gene_name": "nuclear receptor subfamily 4 group A member 3",
                "omim_gene": [
                    "600542"
                ],
                "alias_name": null,
                "gene_symbol": "NR4A3",
                "hgnc_symbol": "NR4A3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:102584137-102629173",
                            "ensembl_id": "ENSG00000119508"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:99821855-99866891",
                            "ensembl_id": "ENSG00000119508"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-09-24"
            },
            "entity_type": "gene",
            "entity_name": "NR4A3",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [],
            "mode_of_inheritance": "Unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FTZ1",
                    "SF-1",
                    "ELP",
                    "AD4BP",
                    "hSF-1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7983",
                "gene_name": "nuclear receptor subfamily 5 group A member 1",
                "omim_gene": [
                    "184757"
                ],
                "alias_name": [
                    "steroidogenic factor 1"
                ],
                "gene_symbol": "NR5A1",
                "hgnc_symbol": "NR5A1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:127243516-127269709",
                            "ensembl_id": "ENSG00000136931"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:124481236-124507430",
                            "ensembl_id": "ENSG00000136931"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1994-06-07"
            },
            "entity_type": "gene",
            "entity_name": "NR5A1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "31513305",
                "38650427",
                "20453312"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Adrenocortical insufficiency, (MIM#612964)",
                "46, XX sex reversal 4, (MIM# 617480)",
                "Premature ovarian failure 7, (MIM#612964)",
                "Spermatogenic failure 8, (MIM#613957)",
                "46XY sex reversal 3, (MIM#612965)"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "N-ras"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7989",
                "gene_name": "NRAS proto-oncogene, GTPase",
                "omim_gene": [
                    "164790"
                ],
                "alias_name": null,
                "gene_symbol": "NRAS",
                "hgnc_symbol": "NRAS",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:115247090-115259515",
                            "ensembl_id": "ENSG00000213281"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:114704469-114716894",
                            "ensembl_id": "ENSG00000213281"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "NRAS",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments",
            "publications": [
                "19966803",
                "26467218",
                "28594414"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Noonan syndrome 6, MIM# 613224"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "D14S46E",
                    "RP27",
                    "NRL-MAF"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8002",
                "gene_name": "neural retina leucine zipper",
                "omim_gene": [
                    "162080"
                ],
                "alias_name": null,
                "gene_symbol": "NRL",
                "hgnc_symbol": "NRL",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:24549316-24584223",
                            "ensembl_id": "ENSG00000129535"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:24080107-24115014",
                            "ensembl_id": "ENSG00000129535"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-05-22"
            },
            "entity_type": "gene",
            "entity_name": "NRL",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "15591106",
                "29385733",
                "21981118",
                "10192380",
                "9344665"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Retinitis pigmentosa 27 - MIM#613750",
                "Enhanced S-cone syndrome 2, MIM# 621371"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0578",
                    "Hs.22998"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8008",
                "gene_name": "neurexin 1",
                "omim_gene": [
                    "600565"
                ],
                "alias_name": null,
                "gene_symbol": "NRXN1",
                "hgnc_symbol": "NRXN1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:50145643-51259674",
                            "ensembl_id": "ENSG00000179915"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:49918505-51225575",
                            "ensembl_id": "ENSG00000179915"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-10-14"
            },
            "entity_type": "gene",
            "entity_name": "NRXN1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "25486015",
                "19896112",
                "21964664",
                "30873608",
                "35101781",
                "22337556",
                "22670139"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Pitt-Hopkins-like syndrome 2 - MIM#614325"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "ARA267",
                    "FLJ22263",
                    "KMT3B"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14234",
                "gene_name": "nuclear receptor binding SET domain protein 1",
                "omim_gene": [
                    "606681"
                ],
                "alias_name": null,
                "gene_symbol": "NSD1",
                "hgnc_symbol": "NSD1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "5:176560026-176727216",
                            "ensembl_id": "ENSG00000165671"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "5:177133025-177300215",
                            "ensembl_id": "ENSG00000165671"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-02-25"
            },
            "entity_type": "gene",
            "entity_name": "NSD1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "16010675",
                "15942875"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Sotos syndrome 1 (MIM#117550), AD"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MMSET",
                    "KMT3G"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:12766",
                "gene_name": "nuclear receptor binding SET domain protein 2",
                "omim_gene": [
                    "602952"
                ],
                "alias_name": [
                    "multiple myeloma SET domain containing protein"
                ],
                "gene_symbol": "NSD2",
                "hgnc_symbol": "NSD2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:1873151-1983934",
                            "ensembl_id": "ENSG00000109685"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:1871424-1982207",
                            "ensembl_id": "ENSG00000109685"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2016-11-18"
            },
            "entity_type": "gene",
            "entity_name": "NSD2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "30345613",
                "31171569",
                "36189577"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Rauch-Steindl syndrome, MIM# 619695",
                "Microcephaly",
                "intellectual disability",
                "Neurodevelopmental disorder, NSD2-associated, GoF, MONDO:0700092"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "XAP104",
                    "H105e3",
                    "SDR31E1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:13398",
                "gene_name": "NAD(P) dependent steroid dehydrogenase-like",
                "omim_gene": [
                    "300275"
                ],
                "alias_name": [
                    "short chain dehydrogenase/reductase family 31E, member 1"
                ],
                "gene_symbol": "NSDHL",
                "hgnc_symbol": "NSDHL",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:151999511-152038273",
                            "ensembl_id": "ENSG00000147383"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:152830967-152869729",
                            "ensembl_id": "ENSG00000147383"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-04-30"
            },
            "entity_type": "gene",
            "entity_name": "NSDHL",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "15689440"
            ],
            "evidence": [
                "Expert Review Green",
                "NHS GMS",
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "CHILD syndrome (MMIM#308050)"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HCA4",
                    "MAGEG1",
                    "MAGEL3",
                    "NSE3"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:7677",
                "gene_name": "NSE3 homolog, SMC5-SMC6 complex component",
                "omim_gene": [
                    "608243"
                ],
                "alias_name": null,
                "gene_symbol": "NSMCE3",
                "hgnc_symbol": "NSMCE3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "15:29560353-29562033",
                            "ensembl_id": "ENSG00000185115"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "15:29264992-29269829",
                            "ensembl_id": "ENSG00000185115"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2015-11-19"
            },
            "entity_type": "gene",
            "entity_name": "NSMCE3",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "27427983"
            ],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Lung disease, immunodeficiency, and chromosome breakage syndrome, MIM#617241"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:29843",
                "gene_name": "NMDA receptor synaptonuclear signaling and neuronal migration factor",
                "omim_gene": [
                    "608137"
                ],
                "alias_name": null,
                "gene_symbol": "NSMF",
                "hgnc_symbol": "NSMF",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:140342022-140353786",
                            "ensembl_id": "ENSG00000165802"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:137447573-137459334",
                            "ensembl_id": "ENSG00000165802"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2013-01-14"
            },
            "entity_type": "gene",
            "entity_name": "NSMF",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "15362570",
                "17235395",
                "21700882"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Hypogonadotropic hypogonadism 9 with or without anosmia, MIM# 614838"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ20303",
                    "TRM4",
                    "Misu"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:25994",
                "gene_name": "NOP2/Sun RNA methyltransferase family member 2",
                "omim_gene": [
                    "610916"
                ],
                "alias_name": [
                    "tRNA methyltransferase 4 homolog (S. cerevisiae)",
                    "Myc-induced SUN-domain-containing protein"
                ],
                "gene_symbol": "NSUN2",
                "hgnc_symbol": "NSUN2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "5:6599352-6633404",
                            "ensembl_id": "ENSG00000037474"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "5:6599239-6633291",
                            "ensembl_id": "ENSG00000037474"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-08-25"
            },
            "entity_type": "gene",
            "entity_name": "NSUN2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "22541559",
                "22541562",
                "21063731",
                "22577224",
                "35126837"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Mental retardation, autosomal recessive 5 - MIM#611091"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "PNT5",
                    "GMP",
                    "cN-II",
                    "SPG65"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8022",
                "gene_name": "5'-nucleotidase, cytosolic II",
                "omim_gene": [
                    "600417"
                ],
                "alias_name": [
                    "purine 5' nucleotidase"
                ],
                "gene_symbol": "NT5C2",
                "hgnc_symbol": "NT5C2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "10:104845940-104953056",
                            "ensembl_id": "ENSG00000076685"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "10:103088017-103193306",
                            "ensembl_id": "ENSG00000076685"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-04-19"
            },
            "entity_type": "gene",
            "entity_name": "NT5C2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "24482476",
                "32153630",
                "29123918",
                "28884889",
                "28327087"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Spastic paraplegia 45, autosomal recessive, MIM# 613162",
                "MONDO:0013165"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "UMPH1",
                    "PSN1",
                    "PN-I",
                    "UMPH",
                    "P5'N-1",
                    "cN-III",
                    "p36",
                    "POMP",
                    "hUMP1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:17820",
                "gene_name": "5'-nucleotidase, cytosolic IIIA",
                "omim_gene": [
                    "606224"
                ],
                "alias_name": [
                    "lupin"
                ],
                "gene_symbol": "NT5C3A",
                "hgnc_symbol": "NT5C3A",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:33053742-33102409",
                            "ensembl_id": "ENSG00000122643"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:33014114-33062797",
                            "ensembl_id": "ENSG00000122643"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2013-03-06"
            },
            "entity_type": "gene",
            "entity_name": "NT5C3A",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "11369620",
                "12714505",
                "30951028",
                "25153905"
            ],
            "evidence": [
                "Expert Review Green",
                "NHS GMS",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Anaemia, haemolytic, due to UMPH1 deficiency, MIM# 266120"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CD73",
                    "eN",
                    "eNT",
                    "CALJA"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8021",
                "gene_name": "5'-nucleotidase ecto",
                "omim_gene": [
                    "129190"
                ],
                "alias_name": null,
                "gene_symbol": "NT5E",
                "hgnc_symbol": "NT5E",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:86159809-86205500",
                            "ensembl_id": "ENSG00000135318"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:85449584-85495791",
                            "ensembl_id": "ENSG00000135318"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-04-19"
            },
            "entity_type": "gene",
            "entity_name": "NT5E",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "21288095"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Calcification of joints and arteries, MIM# 211800"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NT-4/5",
                    "GLC1O"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8024",
                "gene_name": "neurotrophin 4",
                "omim_gene": [
                    "162662"
                ],
                "alias_name": [
                    "neurotrophic factor 4"
                ],
                "gene_symbol": "NTF4",
                "hgnc_symbol": "NTF4",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:49559050-49568333",
                            "ensembl_id": "ENSG00000225950"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:49061066-49065054",
                            "ensembl_id": "ENSG00000225950"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2008-01-31"
            },
            "entity_type": "gene",
            "entity_name": "NTF4",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20806036",
                "19765683",
                "22815630"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Glaucoma 1, open angle, 1O - MIIM#613100"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [
                "disputed"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NTN1L"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8029",
                "gene_name": "netrin 1",
                "omim_gene": [
                    "601614"
                ],
                "alias_name": [
                    "Netrin-1"
                ],
                "gene_symbol": "NTN1",
                "hgnc_symbol": "NTN1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:8924859-9147317",
                            "ensembl_id": "ENSG00000065320"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:9021542-9244000",
                            "ensembl_id": "ENSG00000065320"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-04-15"
            },
            "entity_type": "gene",
            "entity_name": "NTN1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "25763452",
                "28945198",
                "33472083",
                "39648562"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert list",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Mirror movements 4 MIM#618264",
                "Hearing loss disorder, MONDO:0005365, NTN1-related"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0976",
                    "Lmnt1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:23319",
                "gene_name": "netrin G1",
                "omim_gene": [
                    "608818"
                ],
                "alias_name": [
                    "netrin G1f",
                    "Netrin-G1"
                ],
                "gene_symbol": "NTNG1",
                "hgnc_symbol": "NTNG1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:107682629-108026080",
                            "ensembl_id": "ENSG00000162631"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:107140007-107483458",
                            "ensembl_id": "ENSG00000162631"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-12-02"
            },
            "entity_type": "gene",
            "entity_name": "NTNG1",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [],
            "mode_of_inheritance": "Unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA1857",
                    "Lmnt2"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:14288",
                "gene_name": "netrin G2",
                "omim_gene": null,
                "alias_name": [
                    "Netrin-G2"
                ],
                "gene_symbol": "NTNG2",
                "hgnc_symbol": "NTNG2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:135037334-135119921",
                            "ensembl_id": "ENSG00000196358"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:132161676-132244534",
                            "ensembl_id": "ENSG00000196358"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-12-03"
            },
            "entity_type": "gene",
            "entity_name": "NTNG2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "31668703"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Intellectual disability",
                "autism",
                "dysmorphic features",
                "Neurodevelopmental disorder with behavioral abnormalities, absent speech, and hypotonia, MIM#\t618718"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "TRK",
                    "TRKA",
                    "MTC"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8031",
                "gene_name": "neurotrophic receptor tyrosine kinase 1",
                "omim_gene": [
                    "191315"
                ],
                "alias_name": [
                    "high affinity nerve growth factor receptor"
                ],
                "gene_symbol": "NTRK1",
                "hgnc_symbol": "NTRK1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:156785432-156851642",
                            "ensembl_id": "ENSG00000198400"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:156815640-156881850",
                            "ensembl_id": "ENSG00000198400"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1991-07-18"
            },
            "entity_type": "gene",
            "entity_name": "NTRK1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "10233776",
                "19250380",
                "10861667",
                "10982191",
                "20301726",
                "20089052"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Insensitivity to pain, congenital, with anhidrosis - MIM#256800"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "TRKB"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8032",
                "gene_name": "neurotrophic receptor tyrosine kinase 2",
                "omim_gene": [
                    "600456"
                ],
                "alias_name": null,
                "gene_symbol": "NTRK2",
                "hgnc_symbol": "NTRK2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:87283466-87638505",
                            "ensembl_id": "ENSG00000148053"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:84668551-85027070",
                            "ensembl_id": "ENSG00000148053"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1991-07-18"
            },
            "entity_type": "gene",
            "entity_name": "NTRK2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "29100083",
                "15494731",
                "27884935",
                "29100083"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Epileptic encephalopathy, early infantile, 58, MIM# 617830",
                "Obesity, hyperphagia, and developmental delay, MIM# 613886"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ12660",
                    "IND1",
                    "huInd1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:20278",
                "gene_name": "nucleotide binding protein like",
                "omim_gene": [
                    "613621"
                ],
                "alias_name": [
                    "iron-sulfur protein required for NADH dehydrogenase"
                ],
                "gene_symbol": "NUBPL",
                "hgnc_symbol": "NUBPL",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:31959162-32330430",
                            "ensembl_id": "ENSG00000151413"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:31489956-31861224",
                            "ensembl_id": "ENSG00000151413"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-01-07"
            },
            "entity_type": "gene",
            "entity_name": "NUBPL",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20818383",
                "32518176",
                "23553477",
                "31917109",
                "32518176",
                "31787496",
                "30897263",
                "22826544"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Mitochondrial complex I deficiency, nuclear type 21 - MIM#618242"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NUP84"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:29914",
                "gene_name": "nucleoporin 107",
                "omim_gene": [
                    "607617"
                ],
                "alias_name": null,
                "gene_symbol": "NUP107",
                "hgnc_symbol": "NUP107",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:69080514-69136785",
                            "ensembl_id": "ENSG00000111581"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:68686734-68745809",
                            "ensembl_id": "ENSG00000111581"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-03-19"
            },
            "entity_type": "gene",
            "entity_name": "NUP107",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "28280135",
                "28117080",
                "30179222",
                "25558065"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Galloway-Mowat syndrome 7, MIM# 618348"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "founder"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:17859",
                "gene_name": "nucleoporin 188",
                "omim_gene": [
                    "615587"
                ],
                "alias_name": null,
                "gene_symbol": "NUP188",
                "hgnc_symbol": "NUP188",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "9:131709978-131769375",
                            "ensembl_id": "ENSG00000095319"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "9:128947699-129007096",
                            "ensembl_id": "ENSG00000095319"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-03-24"
            },
            "entity_type": "gene",
            "entity_name": "NUP188",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "32021605",
                "28726809",
                "32275884"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Sandestig-Stefanova syndrome, 618804",
                "microcephaly",
                "ID",
                "cataract",
                "structural brain abnormalities",
                "hypoventilation"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0225"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18658",
                "gene_name": "nucleoporin 205",
                "omim_gene": [
                    "614352"
                ],
                "alias_name": null,
                "gene_symbol": "NUP205",
                "hgnc_symbol": "NUP205",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:135242667-135333505",
                            "ensembl_id": "ENSG00000155561"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:135557919-135648757",
                            "ensembl_id": "ENSG00000155561"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-01-07"
            },
            "entity_type": "gene",
            "entity_name": "NUP205",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "26878725"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Nephrotic syndrome, type 13, MIM#616893"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "p62",
                    "DKFZp547L134",
                    "IBSN",
                    "SNDI",
                    "MGC841",
                    "FLJ20822",
                    "FLJ43869"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8066",
                "gene_name": "nucleoporin 62",
                "omim_gene": [
                    "605815"
                ],
                "alias_name": [
                    "nuclear pore glycoprotein p62"
                ],
                "gene_symbol": "NUP62",
                "hgnc_symbol": "NUP62",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:50410082-50433020",
                            "ensembl_id": "ENSG00000213024"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:49906825-49929763",
                            "ensembl_id": "ENSG00000213024"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-01-06"
            },
            "entity_type": "gene",
            "entity_name": "NUP62",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "16786527"
            ],
            "evidence": [
                "Expert Review Amber",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Striatonigral degeneration, infantile - MIM#271930"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "founder"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0095"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:28958",
                "gene_name": "nucleoporin 93",
                "omim_gene": [
                    "614351"
                ],
                "alias_name": null,
                "gene_symbol": "NUP93",
                "hgnc_symbol": "NUP93",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:56764017-56878797",
                            "ensembl_id": "ENSG00000102900"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:56730105-56850286",
                            "ensembl_id": "ENSG00000102900"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-03-19"
            },
            "entity_type": "gene",
            "entity_name": "NUP93",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "26878725",
                "26878725",
                "33578576",
                "30741391"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Nephrotic syndrome, type 12 - MIM#616892"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "MGC7199",
                    "NgBR",
                    "TANGO14"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21042",
                "gene_name": "NUS1 dehydrodolichyl diphosphate synthase subunit",
                "omim_gene": [
                    "610463"
                ],
                "alias_name": [
                    "Nogo-B receptor",
                    "transport and golgi organization 14 homolog (Drosophila)"
                ],
                "gene_symbol": "NUS1",
                "hgnc_symbol": "NUS1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:117996665-118031803",
                            "ensembl_id": "ENSG00000153989"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:117675502-117710640",
                            "ensembl_id": "ENSG00000153989"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2006-11-24"
            },
            "entity_type": "gene",
            "entity_name": "NUS1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "31656175",
                "29100083",
                "32485575",
                "25066056"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Intellectual developmental disorder, autosomal dominant 55, with seizures, MIM#\t617831"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ12614",
                    "NRX"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18008",
                "gene_name": "nucleoredoxin",
                "omim_gene": [
                    "612895"
                ],
                "alias_name": null,
                "gene_symbol": "NXN",
                "hgnc_symbol": "NXN",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:702553-883010",
                            "ensembl_id": "ENSG00000167693"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:799313-979770",
                            "ensembl_id": "ENSG00000167693"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-01-16"
            },
            "entity_type": "gene",
            "entity_name": "NXN",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "29276006"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Robinow syndrome, autosomal recessive 2 618529"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CLRP",
                    "CSNB1A"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8082",
                "gene_name": "nyctalopin",
                "omim_gene": [
                    "300278"
                ],
                "alias_name": null,
                "gene_symbol": "NYX",
                "hgnc_symbol": "NYX",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:41306687-41334963",
                            "ensembl_id": "ENSG00000188937"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:41447434-41475710",
                            "ensembl_id": "ENSG00000188937"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2000-07-31"
            },
            "entity_type": "gene",
            "entity_name": "NYX",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "11062471",
                "11062472",
                "16670814",
                "23714322",
                "34064005",
                "34165036"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Night blindness, congenital stationary (complete), 1A, X-linked MIM#310500"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "OIASI",
                    "IFI-4"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8086",
                "gene_name": "2'-5'-oligoadenylate synthetase 1",
                "omim_gene": [
                    "164350"
                ],
                "alias_name": null,
                "gene_symbol": "OAS1",
                "hgnc_symbol": "OAS1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:113344582-113369990",
                            "ensembl_id": "ENSG00000089127"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:112906777-112933222",
                            "ensembl_id": "ENSG00000089127"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "OAS1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "Other",
            "publications": [
                "34145065",
                "29455859"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Immunodeficiency 100 with pulmonary alveolar proteinosis and hypogammaglobulinaemia, MIM#618042"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HOGA"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8091",
                "gene_name": "ornithine aminotransferase",
                "omim_gene": [
                    "613349"
                ],
                "alias_name": [
                    "Ornithine aminotransferase",
                    "ornithine aminotransferase precursor",
                    "gyrate atrophy"
                ],
                "gene_symbol": "OAT",
                "hgnc_symbol": "OAT",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "10:126085872-126107545",
                            "ensembl_id": "ENSG00000065154"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "10:124397303-124418976",
                            "ensembl_id": "ENSG00000065154"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "OAT",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "1618792",
                "2220818",
                "3339136",
                "3417397",
                "2916581",
                "1737786",
                "33463379"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Gyrate atrophy of choroid and retina with or without ornithinemia - MIM#258870"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0657"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:29092",
                "gene_name": "obscurin like 1",
                "omim_gene": [
                    "610991"
                ],
                "alias_name": null,
                "gene_symbol": "OBSL1",
                "hgnc_symbol": "OBSL1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:220415451-220436581",
                            "ensembl_id": "ENSG00000124006"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:219550729-219571859",
                            "ensembl_id": "ENSG00000124006"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2005-10-20"
            },
            "entity_type": "gene",
            "entity_name": "OBSL1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "21737058",
                "19481195",
                "23018678",
                "19877176"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "3-M syndrome 2, MIM #612921"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "BEY2",
                    "EYCL",
                    "BEY",
                    "BEY1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8101",
                "gene_name": "OCA2 melanosomal transmembrane protein",
                "omim_gene": [
                    "611409"
                ],
                "alias_name": [
                    "melanocyte-specific transporter protein",
                    "P-protein"
                ],
                "gene_symbol": "OCA2",
                "hgnc_symbol": "OCA2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "15:28000021-28344504",
                            "ensembl_id": "ENSG00000104044"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "15:27754875-28099358",
                            "ensembl_id": "ENSG00000104044"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1993-02-05"
            },
            "entity_type": "gene",
            "entity_name": "OCA2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "38030918",
                "41807736",
                "31141302",
                "37650133",
                "41292147"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Albinism, oculocutaneous, type II, MIM# 203200"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "SV/CNV"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "PPP1R115"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8104",
                "gene_name": "occludin",
                "omim_gene": [
                    "602876"
                ],
                "alias_name": [
                    "tight junction protein occludin TM4 minus",
                    "phosphatase 1, regulatory subunit 115"
                ],
                "gene_symbol": "OCLN",
                "hgnc_symbol": "OCLN",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "5:68788119-68853931",
                            "ensembl_id": "ENSG00000197822"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "5:69492292-69558104",
                            "ensembl_id": "ENSG00000197822"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-01-20"
            },
            "entity_type": "gene",
            "entity_name": "OCLN",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20727516",
                "32240828",
                "29192239",
                "28386946"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Pseudo-TORCH syndrome 1, MIM#251290"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "OCRL1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8108",
                "gene_name": "OCRL, inositol polyphosphate-5-phosphatase",
                "omim_gene": [
                    "300535"
                ],
                "alias_name": null,
                "gene_symbol": "OCRL",
                "hgnc_symbol": "OCRL",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:128673826-128726538",
                            "ensembl_id": "ENSG00000122126"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:129539849-129592561",
                            "ensembl_id": "ENSG00000122126"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "OCRL",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "15627218",
                "9199559",
                "33517444"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Oculocerebrorenal syndrome MONDO:0010645",
                "Dent disease 2, MIM# 300555",
                "Lowe syndrome , MIM#309000"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ23657",
                    "AI2A4"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:26300",
                "gene_name": "odontogenesis associated phosphoprotein",
                "omim_gene": [
                    "614829"
                ],
                "alias_name": [
                    "amelogenesis imperfecta type IIA4"
                ],
                "gene_symbol": "C4orf26",
                "hgnc_symbol": "ODAPH",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "4:76481258-76491095",
                            "ensembl_id": "ENSG00000174792"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "4:75556048-75565885",
                            "ensembl_id": "ENSG00000174792"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2017-08-09"
            },
            "entity_type": "gene",
            "entity_name": "C4orf26",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "22901946",
                "27558265"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Amelogenesis imperfecta, type IIA4, MIM# 614832"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "new gene name"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "71-7A",
                    "JBTS10"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:2567",
                "gene_name": "OFD1, centriole and centriolar satellite protein",
                "omim_gene": [
                    "300170"
                ],
                "alias_name": null,
                "gene_symbol": "OFD1",
                "hgnc_symbol": "OFD1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:13752832-13787480",
                            "ensembl_id": "ENSG00000046651"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:13734745-13769353",
                            "ensembl_id": "ENSG00000046651"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-10-01"
            },
            "entity_type": "gene",
            "entity_name": "OFD1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "31373179",
                "23033313",
                "16783569"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert Review Green",
                "Victorian Clinical Genetics Services",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Joubert syndrome 10, 300804",
                "Simpson-Golabi-Behmel syndrome, type 2, 300209",
                "Orofaciodigital syndrome I, 311200",
                "Retinitis pigmentosa 23, 300424"
            ],
            "mode_of_inheritance": "Other",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HMMH",
                    "HOGG1",
                    "OGH1",
                    "MUTM"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8125",
                "gene_name": "8-oxoguanine DNA glycosylase",
                "omim_gene": [
                    "601982"
                ],
                "alias_name": [
                    "8-hydroxyguanine DNA glycosylase",
                    "OGG1 type 1e",
                    "OGG1 type 1d",
                    "OGG1 type 1g",
                    "OGG1 type 1h"
                ],
                "gene_symbol": "OGG1",
                "hgnc_symbol": "OGG1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:9791628-9829903",
                            "ensembl_id": "ENSG00000114026"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:9749944-9788219",
                            "ensembl_id": "ENSG00000114026"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1997-07-22"
            },
            "entity_type": "gene",
            "entity_name": "OGG1",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "10987279",
                "29305130"
            ],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Renal cell carcinoma, clear cell, somatic MIM#144700"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "O-GLCNAC",
                    "HRNT1",
                    "MGC22921",
                    "FLJ23071",
                    "OGT1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8127",
                "gene_name": "O-linked N-acetylglucosamine (GlcNAc) transferase",
                "omim_gene": [
                    "300255"
                ],
                "alias_name": [
                    "UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase"
                ],
                "gene_symbol": "OGT",
                "hgnc_symbol": "OGT",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:70752933-70795747",
                            "ensembl_id": "ENSG00000147162"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:71533083-71575897",
                            "ensembl_id": "ENSG00000147162"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-12-03"
            },
            "entity_type": "gene",
            "entity_name": "OGT",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "28302723",
                "28584052",
                "31296563",
                "31627256",
                "29769320",
                "29606577"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Mental retardation, X-linked 106, MIM# 300997"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "NTG",
                    "KIAA0567",
                    "FLJ12460",
                    "NPG",
                    "MGM1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8140",
                "gene_name": "OPA1, mitochondrial dynamin like GTPase",
                "omim_gene": [
                    "605290"
                ],
                "alias_name": [
                    "mitochondrial dynamin-like GTPase",
                    "dynamin-like guanosine triphosphatase",
                    "Dynamin-like 120 kDa protein, mitochondrial"
                ],
                "gene_symbol": "OPA1",
                "hgnc_symbol": "OPA1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "3:193310933-193415612",
                            "ensembl_id": "ENSG00000198836"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "3:193593144-193697823",
                            "ensembl_id": "ENSG00000198836"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1987-09-11"
            },
            "entity_type": "gene",
            "entity_name": "OPA1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "30165240"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert Review Green",
                "Victorian Clinical Genetics Services",
                "Australian Genomics Health Alliance Mitochondrial Flagship",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "OPA1-related optic atrophy with or without extraocular features, MONDO:0800181"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ22187",
                    "MGA3"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8142",
                "gene_name": "OPA3, outer mitochondrial membrane lipid metabolism regulator",
                "omim_gene": [
                    "606580"
                ],
                "alias_name": null,
                "gene_symbol": "OPA3",
                "hgnc_symbol": "OPA3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "19:46030685-46105470",
                            "ensembl_id": "ENSG00000125741"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "19:45527427-45602212",
                            "ensembl_id": "ENSG00000125741"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-03-12"
            },
            "entity_type": "gene",
            "entity_name": "OPA3",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "Other",
            "publications": [
                "25159689",
                "31119193",
                "31928268"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "3-methylglutaconic aciduria, type III (MGA3) (MIM#258501), AR",
                "Optic atrophy 3 with cataract (MIM#165300), AD"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic (but BIALLELIC mutations cause a more SEVERE disease form), autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "OPCM",
                    "OBCAM",
                    "IGLON1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8143",
                "gene_name": "opioid binding protein/cell adhesion molecule like",
                "omim_gene": [
                    "600632"
                ],
                "alias_name": [
                    "IgLON family member 1"
                ],
                "gene_symbol": "OPCML",
                "hgnc_symbol": "OPCML",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "11:132284871-133402414",
                            "ensembl_id": "ENSG00000183715"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "11:132414977-133532519",
                            "ensembl_id": "ENSG00000183715"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1993-12-13"
            },
            "entity_type": "gene",
            "entity_name": "OPCML",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Ovarian cancer, somatic, MIM#167000"
            ],
            "mode_of_inheritance": "Unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "OPN1",
                    "ARHGAP41"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8148",
                "gene_name": "oligophrenin 1",
                "omim_gene": [
                    "300127"
                ],
                "alias_name": null,
                "gene_symbol": "OPHN1",
                "hgnc_symbol": "OPHN1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:67262186-67653755",
                            "ensembl_id": "ENSG00000079482"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:68042344-68433913",
                            "ensembl_id": "ENSG00000079482"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1998-05-12"
            },
            "entity_type": "gene",
            "entity_name": "OPHN1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "20528889",
                "9582072",
                "12807966",
                "16221952"
            ],
            "evidence": [
                "Expert Review Green",
                "Expert list",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance, MIM#300486"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "OPLA",
                    "5-Opase"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8149",
                "gene_name": "5-oxoprolinase, ATP-hydrolysing",
                "omim_gene": [
                    "614243"
                ],
                "alias_name": null,
                "gene_symbol": "OPLAH",
                "hgnc_symbol": "OPLAH",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "8:145106167-145118735",
                            "ensembl_id": "ENSG00000178814"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "8:144051266-144063965",
                            "ensembl_id": "ENSG00000178814"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-12-10"
            },
            "entity_type": "gene",
            "entity_name": "OPLAH",
            "confidence_level": "2",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "27604308",
                "27477828"
            ],
            "evidence": [
                "Expert Review Amber",
                "Expert Review Amber",
                "NHS GMS",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "5-oxoprolinase deficiency MIM#260005",
                "Disorders of the gamma-glutamyl cycle"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "disputed"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "COD5"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:9936",
                "gene_name": "opsin 1, long wave sensitive",
                "omim_gene": [
                    "300822"
                ],
                "alias_name": [
                    "cone dystrophy 5 (X-linked)"
                ],
                "gene_symbol": "OPN1LW",
                "hgnc_symbol": "OPN1LW",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:153409698-153424507",
                            "ensembl_id": "ENSG00000102076"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:154144224-154159032",
                            "ensembl_id": "ENSG00000102076"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "OPN1LW",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "25168334",
                "32860923"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Blue cone monochromacy - MIM#303700",
                "Colourblindness, protan - MIM#303900"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [
                "SV/CNV"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "OPN1MW1",
                    "COD5"
                ],
                "biotype": null,
                "hgnc_id": "HGNC:4206",
                "gene_name": "opsin 1, medium wave sensitive",
                "omim_gene": [
                    "300821"
                ],
                "alias_name": [
                    "cone dystrophy 5 (X-linked)"
                ],
                "gene_symbol": "OPN1MW",
                "hgnc_symbol": "OPN1MW",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:153448107-153461633",
                            "ensembl_id": "ENSG00000147380"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:154182596-154196135",
                            "ensembl_id": "ENSG00000268221"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "OPN1MW",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "25168334",
                "32860923"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Blue cone monochromacy - MIM#303700",
                "Colourblindness, deutan - MIM#303800"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, biallelic mutations in females",
            "tags": [
                "SV/CNV"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "BOP",
                    "CBT"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:1012",
                "gene_name": "opsin 1, short wave sensitive",
                "omim_gene": [
                    "613522"
                ],
                "alias_name": [
                    "color blindness, tritan",
                    "blue-sensitive opsin"
                ],
                "gene_symbol": "OPN1SW",
                "hgnc_symbol": "OPN1SW",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "7:128412545-128415844",
                            "ensembl_id": "ENSG00000128617"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "7:128772491-128775790",
                            "ensembl_id": "ENSG00000128617"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "OPN1SW",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "1531728",
                "2937147",
                "22065927",
                "32400513",
                "31944634"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Colourblindness, tritan - MIM#190900"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "OR6-6"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8261",
                "gene_name": "olfactory receptor family 2 subfamily J member 3",
                "omim_gene": [
                    "615016"
                ],
                "alias_name": null,
                "gene_symbol": "OR2J3",
                "hgnc_symbol": "OR2J3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:29079668-29080603",
                            "ensembl_id": "ENSG00000204701"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:29108059-29114770",
                            "ensembl_id": "ENSG00000204701"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-12-09"
            },
            "entity_type": "gene",
            "entity_name": "OR2J3",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [],
            "mode_of_inheritance": "Unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "FLJ14466",
                    "CRACM1"
                ],
                "biotype": null,
                "hgnc_id": "HGNC:25896",
                "gene_name": "ORAI calcium release-activated calcium modulator 1",
                "omim_gene": [
                    "610277"
                ],
                "alias_name": [
                    "calcium release-activated calcium modulator 1"
                ],
                "gene_symbol": "ORAI1",
                "hgnc_symbol": "ORAI1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "12:122064455-122080583",
                            "ensembl_id": "ENSG00000182500"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "12:121626550-121642677",
                            "ensembl_id": "ENSG00000276045"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2007-08-14"
            },
            "entity_type": "gene",
            "entity_name": "ORAI1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "Other",
            "publications": [
                "31448844"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Immunodeficiency 9, MIM#\t612782",
                "Myopathy, tubular aggregate, 2, MIM#\t615883"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HSORC1",
                    "PARC1"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8487",
                "gene_name": "origin recognition complex subunit 1",
                "omim_gene": [
                    "601902"
                ],
                "alias_name": [
                    "origin recognition complex, subunit 1, S. cerevisiae, homolog-like",
                    "origin recognition complex 1",
                    "replication control protein 1"
                ],
                "gene_symbol": "ORC1",
                "hgnc_symbol": "ORC1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "1:52838501-52870131",
                            "ensembl_id": "ENSG00000085840"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "1:52372829-52404459",
                            "ensembl_id": "ENSG00000085840"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2010-10-12"
            },
            "entity_type": "gene",
            "entity_name": "ORC1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "21358633",
                "21358632",
                "21358631",
                "23023959"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Meier-Gorlin syndrome 1, MIM# 224690",
                "MONDO:0009143"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HsORC4",
                    "Orc4p"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8490",
                "gene_name": "origin recognition complex subunit 4",
                "omim_gene": [
                    "603056"
                ],
                "alias_name": null,
                "gene_symbol": "ORC4",
                "hgnc_symbol": "ORC4",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:148687968-148779147",
                            "ensembl_id": "ENSG00000115947"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:147930397-148021604",
                            "ensembl_id": "ENSG00000115947"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2010-10-12"
            },
            "entity_type": "gene",
            "entity_name": "ORC4",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "21358632",
                "21358631",
                "23023959",
                "22333897"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Meier-Gorlin syndrome 2, MIM# 613800"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:17151",
                "gene_name": "origin recognition complex subunit 6",
                "omim_gene": [
                    "607213"
                ],
                "alias_name": null,
                "gene_symbol": "ORC6",
                "hgnc_symbol": "ORC6",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:46723555-46732306",
                            "ensembl_id": "ENSG00000091651"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:46689643-46698394",
                            "ensembl_id": "ENSG00000091651"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2010-10-12"
            },
            "entity_type": "gene",
            "entity_name": "ORC6",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "21358632",
                "22333897",
                "25691413",
                "26139588"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Meier-Gorlin syndrome 3, MIM# 613803"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:16038",
                "gene_name": "ORMDL sphingolipid biosynthesis regulator 3",
                "omim_gene": [
                    "610075"
                ],
                "alias_name": null,
                "gene_symbol": "ORMDL3",
                "hgnc_symbol": "ORMDL3",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "17:38077294-38083854",
                            "ensembl_id": "ENSG00000172057"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "17:39921041-39927601",
                            "ensembl_id": "ENSG00000172057"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-07-27"
            },
            "entity_type": "gene",
            "entity_name": "ORMDL3",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [],
            "mode_of_inheritance": "Unknown",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "KIAA0772",
                    "ORP-2",
                    "DFNA67"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:15761",
                "gene_name": "oxysterol binding protein like 2",
                "omim_gene": [
                    "606731"
                ],
                "alias_name": null,
                "gene_symbol": "OSBPL2",
                "hgnc_symbol": "OSBPL2",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "20:60813580-60871268",
                            "ensembl_id": "ENSG00000130703"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "20:62231922-62296213",
                            "ensembl_id": "ENSG00000130703"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-05-31"
            },
            "entity_type": "gene",
            "entity_name": "OSBPL2",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "25077649",
                "25759012",
                "31451425",
                "30894143",
                "38701954"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Deafness, autosomal dominant 67 - MIM#616340"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "PRSMG1",
                    "GCPL1",
                    "OSGEP1",
                    "KAE1",
                    "TCS3"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:18028",
                "gene_name": "O-sialoglycoprotein endopeptidase",
                "omim_gene": [
                    "610107"
                ],
                "alias_name": null,
                "gene_symbol": "OSGEP",
                "hgnc_symbol": "OSGEP",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "14:20914570-20923264",
                            "ensembl_id": "ENSG00000092094"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "14:20446411-20455105",
                            "ensembl_id": "ENSG00000092094"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-01-23"
            },
            "entity_type": "gene",
            "entity_name": "OSGEP",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "28805828",
                "28272532"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Galloway-Mowat syndrome 3, MIM# 617729"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "OSMRB"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8507",
                "gene_name": "oncostatin M receptor",
                "omim_gene": [
                    "601743"
                ],
                "alias_name": null,
                "gene_symbol": "OSMR",
                "hgnc_symbol": "OSMR",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "5:38845960-38945698",
                            "ensembl_id": "ENSG00000145623"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "5:38845858-38945596",
                            "ensembl_id": "ENSG00000145623"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "1999-02-17"
            },
            "entity_type": "gene",
            "entity_name": "OSMR",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "19375894",
                "19528426",
                "25054142",
                "20507362",
                "19690585",
                "40970115"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Amyloidosis, primary localized cutaneous, 1 - MIM#105250",
                "Inborn error of immunity, MONDO:0003778, OSMR-related"
            ],
            "mode_of_inheritance": "BOTH monoallelic and biallelic, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8111",
                "gene_name": "odd-skipped related transciption factor 1",
                "omim_gene": [
                    "608891"
                ],
                "alias_name": null,
                "gene_symbol": "OSR1",
                "hgnc_symbol": "OSR1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "2:19551246-19558414",
                            "ensembl_id": "ENSG00000143867"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "2:19351485-19358653",
                            "ensembl_id": "ENSG00000143867"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2004-11-26"
            },
            "entity_type": "gene",
            "entity_name": "OSR1",
            "confidence_level": "1",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Red",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Congenital heart disease, MONDO:0005453"
            ],
            "mode_of_inheritance": "MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "HSPC019",
                    "GL"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:21652",
                "gene_name": "osteopetrosis associated transmembrane protein 1",
                "omim_gene": [
                    "607649"
                ],
                "alias_name": [
                    "CLCN7 accessory beta subunit"
                ],
                "gene_symbol": "OSTM1",
                "hgnc_symbol": "OSTM1",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "6:108362613-108487058",
                            "ensembl_id": "ENSG00000081087"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "6:108041409-108165854",
                            "ensembl_id": "ENSG00000081087"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2003-10-06"
            },
            "entity_type": "gene",
            "entity_name": "OSTM1",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "12627228",
                "15108279",
                "16813530",
                "23772242",
                "32048120"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Osteopetrosis, autosomal recessive 5 (MIM#259720)"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:8512",
                "gene_name": "ornithine carbamoyltransferase",
                "omim_gene": [
                    "300461"
                ],
                "alias_name": null,
                "gene_symbol": "OTC",
                "hgnc_symbol": "OTC",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "X:38211798-38280703",
                            "ensembl_id": "ENSG00000036473"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "X:38352545-38421450",
                            "ensembl_id": "ENSG00000036473"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2001-06-22"
            },
            "entity_type": "gene",
            "entity_name": "OTC",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Ornithine transcarbamylase deficiency - MIM#311250"
            ],
            "mode_of_inheritance": "X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)",
            "tags": [
                "treatable"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        },
        {
            "gene_data": {
                "alias": [
                    "CT108"
                ],
                "biotype": "protein_coding",
                "hgnc_id": "HGNC:16378",
                "gene_name": "otoancorin",
                "omim_gene": [
                    "607038"
                ],
                "alias_name": [
                    "cancer/testis antigen 108"
                ],
                "gene_symbol": "OTOA",
                "hgnc_symbol": "OTOA",
                "hgnc_release": "2017-11-03",
                "ensembl_genes": {
                    "GRch37": {
                        "82": {
                            "location": "16:21689835-21772050",
                            "ensembl_id": "ENSG00000155719"
                        }
                    },
                    "GRch38": {
                        "90": {
                            "location": "16:21678514-21760729",
                            "ensembl_id": "ENSG00000155719"
                        }
                    }
                },
                "hgnc_date_symbol_changed": "2002-07-05"
            },
            "entity_type": "gene",
            "entity_name": "OTOA",
            "confidence_level": "3",
            "penetrance": null,
            "mode_of_pathogenicity": "",
            "publications": [
                "11972037",
                "19888295",
                "23173898",
                "16460646",
                "26029705",
                "26969326",
                "23129639"
            ],
            "evidence": [
                "Expert Review Green",
                "Victorian Clinical Genetics Services"
            ],
            "phenotypes": [
                "Deafness, autosomal recessive 22, MIM# 607039"
            ],
            "mode_of_inheritance": "BIALLELIC, autosomal or pseudoautosomal",
            "tags": [
                "SV/CNV"
            ],
            "panel": {
                "id": 137,
                "hash_id": null,
                "name": "Mendeliome",
                "disease_group": "",
                "disease_sub_group": "",
                "description": "The Mendeliome contains genes currently associated with Mendelian gene disorders.\r\n\r\nThe Mendeliome is intended to be used to facilitate panel-agnostic analysis, particularly in complex paediatric patients with multi-system features, while still limiting analysis to genes with published evidence for gene-disease association and minimising the chance of incidental findings. It therefore excludes genes listed in the Incidentalome, such as those associated with some cardiac disorders, cancer predisposition syndromes, and neurodegenerative diseases. If analysis of these genes is required, the relevant disease-specific panel (e.g. Adult Additional Findings, Neurodegenerative Disease_Adult Onset, Regression, Breast Cancer) should be requested.\r\n\r\nPlease note that mitochondrially-encoded genes may only be analysed as part of some genomic tests, e.g. WGS with appropriate accreditation in place. If uncertain, please contact your test provider.\r\n\r\nSTRs are currently on this panel as 'grey' due to lack of clinical accreditation for STR analysis in Australian laboratories.\r\n\r\nThis panel was originally developed by VCGS and is a consensus panel used by RMH.",
                "status": "public",
                "version": "1.4754",
                "version_created": "2026-04-20T20:37:57.116193+10:00",
                "relevant_disorders": [],
                "stats": {
                    "number_of_genes": 6014,
                    "number_of_strs": 43,
                    "number_of_regions": 7
                },
                "types": [
                    {
                        "name": "Victorian Clinical Genetics Services",
                        "slug": "victorian-clinical-genetics-services",
                        "description": "Panel used by VCGS."
                    },
                    {
                        "name": "Royal Melbourne Hospital",
                        "slug": "royal-melbourne-hospital",
                        "description": "Royal Melbourne Hospital"
                    },
                    {
                        "name": "Rare Disease",
                        "slug": "rare-disease",
                        "description": "Rare disease panels"
                    }
                ],
                "child_panel_ids": []
            },
            "transcript": null
        }
    ]
}